Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review

Planning for Posttrial Access to Antiretroviral Treatment for Research Participants in Developing Countries

(2009) Seema Shah et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Access to Medications and Medical Care After Participation in HIV Clinical Trials: A Systematic Review of Trial Protocols and Informed Consent Documents

(2009) Andrea L. Ciaranello et al.   HIV CLINICAL TRIALS

Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study

(2009) N Sofaer et al.   JOURNAL OF MEDICAL ETHICS

REPORTING OF INFORMED CONSENT, STANDARD OF CARE AND POST-TRIAL OBLIGATIONS IN GLOBAL RANDOMIZED INTERVENTION TRIALS: A SYSTEMATIC SURVEY OF REGISTERED TRIALS

(2008) EMMA R.M. COHEN et al.   Developing World Bioethics

Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?

(2008) Z. Zong   JOURNAL OF MEDICAL ETHICS

Systematic reviews of empirical bioethics

(2008) D Strech et al.   JOURNAL OF MEDICAL ETHICS

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal